Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Urinary Bladder Neoplasms × Gemcitabine × Clear all

Phase

Status

Sponsor Class

OTHER 73 INDUSTRY 31 NETWORK 16 NIH 11 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 6 Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Hodgkin Disease 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Small Cell Lung Carcinoma 1 Renal Insufficiency 1 Neoplastic Cells, Circulating 1 Nasopharyngeal Carcinoma 1 Locally Advanced Cervical Cancer 1 Gallbladder Neoplasms 1 Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1 Cholangiocarcinoma 1

Interventions

Saline Solution 2 apatorsen 1 Standard of Care 1 Mitomycin 1 Magnetic Resonance Imaging 1 Magnesium Sulfate 1 Injections, Epidural 1 Gemcitabine 1 Dexmedetomidine 1 Cytological Techniques 1 Cystoscopy 1 Cisplatin 1 Blood Transfusion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06388720 2025-09-15

IMGeS

National Cancer Center, Korea

Phase 2 Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡